Form 8-K · Current report
Prologis 8-K, filed Oct 15, 2026
- Filed
- CIK
- 0001045609
- Accession no.
- 0001193125-26-422375
Summary
Prologis issued a press release and supplemental information reporting third quarter 2026 financial results, including net earnings attributable to common stockholders of $816 million and Core FFO of $1,545 million, and reaffirmed full-year 2026 guidance for net earnings of $4.05–$4.15 per share and Core FFO of $6.25–$6.29 per share.
Key points
- Prologis reported Q3 2026 rental and other revenues of $2.22 billion and total revenues of $2.39 billion, up from $2.06 billion and $2.21 billion a year earlier.
- Q3 2026 net earnings attributable to common stockholders were $816 million, or $0.86 per diluted share, versus $763 million and $0.82 a year earlier.
- Core FFO attributable to common stockholders/unitholders was $1,545 million, or $1.60 per diluted share, compared with $1,426 million and $1.49 a year earlier.
- 2026 guidance assumes average occupancy of 95.25–95.50% and same-store NOI growth (cash, Prologis Share) of 7.00–7.50%.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 2.02Results of Operations and Financial Condition
- 7.01Regulation FD Disclosure
- 9.01Financial Statements and Exhibits
From the filing
Item 2.02. Results of Operations and Financial Condition (Prologis, Inc.) and Item 7.01. Regulation FD Disclosure (Prologis, Inc. and Prologis, L.P.). On October 15, 2026, Prologis, Inc., the general partner of Prologis, L.P., issued a press release announcing third quarter 2026 financial results. A copy of the supplemental information as well as the press release is furnished with this report as Exhibit 99.1 and Exhibit 99.2, respectively, and incorporated herein by reference. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.